Beginning September 5, 2008 the FDA will post a quarterly list of drugs that are being evaluated for potential safety concerns. The drugs are identified through the FDA’s Adverse Event Reporting System, a computerized information database designed to support the FDA’s drug safety surveillance program. The appearance of a drug (and the related safety issue) on the list does not mean there is necessarily a problem with the drug. It simply means that the FDA is looking into a potential safety concern that may or may not be related to the drug. The FDA is stressing that this list is not to be used as a warning alarm for those who are taking medications. Rather, it is merely a means of communication for the consumer to know when the FDA is in the early stages of looking into a potential safety problem. See the first quarterly list.
September 9, 2008
Follow us on Twitter
Become a fan on Facebook
Dr. Steven Chang, the author of DailyDose, is a staff physician with Kosmix RightHealth. Dr. Chang practices Family Medicine at the University of California Davis Medical Center, where his medical interests include both pediatric and geriatric care, public health, gay and lesbian health, and sleep medicine. Dr. Chang trained at the Stanford University affiliated O'Connor Hospital, and was a research fellow at the National Institute of Health. He holds an M.D. from McGill University and a BA in Public Health from Johns Hopkins University.